Latest Kaiser Health News Stories
Both President Donald Trump and Sen. Rand Paul (R-Ky.) signaled last week that executive action was in the works that would give these plans a boost.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times, and Joanne Kenen of Politico discuss Congress’ tardiness in renewing the Children’s Health Insurance Plan (CHIP), and play the parlor game of who might become the new secretary of Health and Human Services. Also, the pod panel interviews Rep. John Larson (D-Conn.) about his new Medicare buy-in bill.
Doctors offering this care charge a monthly fee for services that can be handled in the office. But patient advocates warn it is not insurance and offers no coverage for hospital or specialist care.
Technical glitches with a mandatory credentialing course are, many say, the latest in a series of complications that could make it harder to help people get coverage.
Tom Price resigned from running the Department of Health and Human Services after a series of news stories detailing how he tallied more than $400,000 in private plane travel paid for by taxpayers.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post discuss what happens now that Republicans have officially failed in their latest effort to overhaul Obamacare. Plus an interview with Bruce Lesley of First Focus about the fate of the Children’s Health Insurance Program.
Even though the Affordable Care Act has dodged another legislative bullet, it still faces challenges.
Hundreds of protesters were turned away from the Senate’s public hearing on the Graham-Cassidy bill to replace the Affordable Care Act, but they made their feelings known outside the door.
The statement from the Maine senator came after the Congressional Budget Office said the bill would cause millions of people to become uninsured.
Those relying on the federal government’s safety net are grandmothers, the kid next door, your supermarket cashier — maybe even you.
In the GOP’s attempt to repeal the Affordable Care Act, California would lose a lot of federal funding. Texas would gain a lot in the short term, but experts worry Texas would not use the money well.
The shutdown, which raised protests from navigator groups, will occur from midnight Saturday to 12 p.m. Sunday on all but one weekend.
The measure proposed by Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) would disrupt the existing health system more than any of the measures considered so far this year, according to supporters and critics.
Sept. 30 marks the end of Medicare’s temporary offer to waive penalties for certain late Medicare enrollees with Affordable Care Act insurance coverage.
The Affordable Care Act gave some Americans the chance to strike out on their own in new business ventures because they didn’t have to worry about keeping a job just for health insurance. But the repeal-and-replace efforts reignited this week create uncertainty about whether they can count on that insurance option in the future.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss Senate Republicans’ last-ditch effort to upend the Affordable Care Act ahead of a Sept. 30 deadline.
Republicans are making a concerted push to unite around a bill sponsored by Sens. Lindsey Graham and Bill Cassidy that would gut major provisions of the federal health law.
Employers report the sixth consecutive year of small increases, but workers at small firms feel the biggest pinch, according to the Kaiser Family Foundation survey.
The Trump administration has dramatically trimmed money for the groups that help people enroll in marketplace plans, but those navigators say federal officials have unrealistic assessments of the tasks involved.
A federal drug program blocks rural hospitals from getting discounts on rare-disease drugs, forcing staff to cut back on supplies of lifesaving medicines.